1 Introduction Psychedelic-assisted therapy (PAT) is emerging as a promising mental health intervention (Bahji et al. 2020; Carhart-Harris et al. 2021; Garcia-Romeu et al. 2014; Goldberg et al. 2020; Griffiths 2016; Moreno et al. 2006). In 2023, the Australian Therapeutic Goods Administration down-scheduled psilocybin and MDMA, allowing use under strict conditions by authorized psychiatrists and their teams (Therapeutic Goods Administration 2023).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Rachel
Contact Rachel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack